iCubate Inc:企業の製品パイプライン分析

◆英語タイトル:iCubate Inc - Product Pipeline Analysis, 2020 Update
◆商品コード:GDME2747864PD
◆発行会社(調査会社):GlobalData
◆発行日:2021年1月
◆ページ数:27
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Medical Devices
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD1,500 ⇒換算¥165,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD2,250 ⇒換算¥247,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
iCubate Inc (iCubate) is a molecular diagnostic company that provides molecular diagnostic and in vitro diagnostic testing devices for syndromic testing. It develops cassettes and assays. The company’s pipeline products include flu typing cassette; HAI cassette; and STD cassette. iCubate utilizes multiplex polymerase chain reaction (mPCR) technology which is an integrated platform for automated sample preparation, amplification and detection preparation. The company also developing iCubate 2.0, an open platform that develops and markets mPCR assays. Its products are widely used in the treatment of infectious diseases. iCubate is headquartered in Huntsville, Alabama, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company iCubate Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
iCubate Inc Company Overview
iCubate Inc Company Snapshot
iCubate Inc Pipeline Products and Ongoing Clinical Trials Overview
iCubate Inc – Pipeline Analysis Overview
iCubate Inc – Key Facts
iCubate Inc – Major Products and Services
iCubate Inc Pipeline Products by Development Stage
iCubate Inc Pipeline Products Overview
iC-COVID19 Assay
iC-COVID19 Assay Product Overview
iC-GN Assay – Gram-Negative Rods
iC-GN Assay – Gram-Negative Rods Product Overview
iC-GPC Assay
iC-GPC Assay Product Overview
iC-Myco Assay
iC-Myco Assay Product Overview
iCubate Inc – Key Competitors
iCubate Inc – Key Employees
iCubate Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture
Recent Developments
iCubate Inc, Recent Developments
Aug 08, 2019: iCubate presents data on the iC-Myco Assay at the American Association of Clinical Chemistry Meeting
Aug 02, 2019: iCubate earns FDA “breakthrough device” designation for latest assay
Jul 23, 2019: Huntsville’s iCubate announces FDA clearance for innovative bloodstream infection testing
Jul 12, 2019: Icubate earns FDA clearance for latest assay
Jun 27, 2019: iCubate receives CE IVD mark for bloodstream infection assay
Aug 23, 2017: iCubate Receives CE Mark for the iC-GPC Assay
Aug 22, 2017: iCubate Receives CE Mark for the iC-GPC Assay for use on the iC-System
Aug 10, 2017: iCubate Earns FDA Clearance for iC­-GPC Assay A Unique Diagnostic Solution for the diagnosis of Bloodstream Infections
Aug 10, 2017: iCubate Earns FDA Clearance for iC-­System for the diagnosis of Bloodstream Infections
Oct 06, 2016: iCubate forms Scientific Advisory Board
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

List of Tables
iCubate Inc Pipeline Products and Ongoing Clinical Trials Overview
iCubate Inc Pipeline Products by Equipment Type
iCubate Inc Pipeline Products by Indication
iCubate Inc, Key Facts
iCubate Inc, Major Products and Services
iCubate Inc Number of Pipeline Products by Development Stage
iCubate Inc Pipeline Products Summary by Development Stage
iC-COVID19 Assay - Product Status
iC-COVID19 Assay - Product Description
iC-GN Assay - Gram-Negative Rods - Product Status
iC-GN Assay - Gram-Negative Rods - Product Description
iC-GPC Assay - Product Status
iC-GPC Assay - Product Description
iC-Myco Assay - Product Status
iC-Myco Assay - Product Description
iCubate Inc, Key Employees
iCubate Inc, Joint Venture
Glossary

★海外企業調査レポート[iCubate Inc:企業の製品パイプライン分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Arris International Plc:企業のM&A・事業提携・投資動向
    Arris International Plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Arris International Plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisition …
  • Syros Pharmaceuticals Inc (SYRS):製薬・医療:M&Aディール及び事業提携情報
    Summary Syros Pharmaceuticals Inc (Syros) is a biopharmaceutical company that develops medicines for the treatment of cancer, immune-mediated diseases, and other diseases. The company’s pipeline products under clinical trials include SY-1425, an oral, potent and selective RARa agonist that is used t …
  • Bank J.Van Breda & C° NV:企業の戦略・SWOT・財務情報
    Bank J.Van Breda & C° NV - Strategy, SWOT and Corporate Finance Report Summary Bank J.Van Breda & C° NV - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Beach Energy Limited:企業の戦略・SWOT・財務情報
    Beach Energy Limited - Strategy, SWOT and Corporate Finance Report Summary Beach Energy Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Global Imaging Systems, Inc.:企業のM&A・事業提携・投資動向
    Global Imaging Systems, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Global Imaging Systems, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and a …
  • Tanami Gold NL:企業の戦略・SWOT・財務分析
    Tanami Gold NL - Strategy, SWOT and Corporate Finance Report Summary Tanami Gold NL - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Restalia Grupo de Eurorestauracion SL:企業の戦略・SWOT・財務分析
    Restalia Grupo de Eurorestauracion SL - Strategy, SWOT and Corporate Finance Report Summary Restalia Grupo de Eurorestauracion SL - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • ThreeD Capital:企業のM&A・事業提携・投資動向
    ThreeD Capital - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's ThreeD Capital Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestmen …
  • Singapore Petroleum Co Ltd:企業の戦略的SWOT分析
    Singapore Petroleum Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • F. Hoffmann-La Roche Ltd:戦略・SWOT・企業財務分析
    F. Hoffmann-La Roche Ltd - Strategy, SWOT and Corporate Finance Report Summary F. Hoffmann-La Roche Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Triveni Turbine Ltd (TRITURBINE):企業の財務・戦略的SWOT分析
    Triveni Turbine Ltd (TRITURBINE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Swedish Orphan Biovitrum AB (SOBI):製薬・医療:M&Aディール及び事業提携情報
    Summary Swedish Orphan Biovitrum AB (Sobi), formerly Biovitrum AB, is an integrated biopharmaceutical company that focuses on the development of products for the treatment of rare diseases. The company specializes in biotechnology with prime capabilities in protein biochemistry and biologics manufac …
  • Makedonijaturist AD Skopje:企業の戦略・SWOT・財務情報
    Makedonijaturist AD Skopje - Strategy, SWOT and Corporate Finance Report Summary Makedonijaturist AD Skopje - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Sioux Manufacturing Corporation:企業の戦略・SWOT・財務情報
    Sioux Manufacturing Corporation - Strategy, SWOT and Corporate Finance Report Summary Sioux Manufacturing Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • ImmunoCellular Therapeutics Ltd (IMUC):医療機器:M&Aディール及び事業提携情報
    Summary ImmunoCellular Therapeutics Ltd (IMCU) is a clinical-stage biotechnology company which develops immune-based therapies for the treatment of various cancers. The product pipeline of the company includes active immunotherapies and patented monoclonal antibodies. IMCU’s immunotherapies product …
  • Commonwealth Scientific and Industrial Research Organisation-医療機器分野:企業M&A・提携分析
    Summary Commonwealth Scientific and Industrial Research Organisation (CSIRO) is a national science agency that conducts research in climate adaptation, bio-security, renewable and energy, farming and food production, and information technology, and mining and manufacturing services, and others. The …
  • GW Pharmaceuticals Plc (GWP)-医療機器分野:企業M&A・提携分析
    Summary GW Pharmaceuticals plc (GW Pharmaceuticals) is a biopharmaceutical company which discovers, develops and commercializes innovative therapeutics from its proprietary cannabinoid product platform. The company’s commercialized product, Sativex is a plant-derived cannabinoid prescription drug, f …
  • Orange and Rockland Utilities, Inc.:企業の戦略的SWOT分析
    Orange and Rockland Utilities, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Alexza Pharmaceuticals Inc:企業の戦略的SWOT分析
    Alexza Pharmaceuticals Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Jiangsu Hengrui Medicine Co Ltd (600276):企業の財務・戦略的SWOT分析
    Jiangsu Hengrui Medicine Co Ltd (600276) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆